Urothelial Carcinoma-In-Situ : p53

Section Editor: Dharam M. Ramnani, MD

Virginia Urology, Richmond, VA, USA

Previous

Image 25 of 50

Next

Image Description

Diffuse p53 immunoreactivity can help distinguish urothelial CIS (shown here) from reactive atypia. Same case as the previous image.
Previous

Image 25 of 50

Next